What is the selling price of Mitotane in China?

Mitotane(Mitotane) is a drug specifically indicated foradrenal cancer and is considered an important treatment option for this disease in international medical guidelines. Its unique feature is that it can selectively destroy adrenocortical cells, inhibit tumor cell growth, and reduce excessive secretion of hormones, so it is of great significance to patients with advanced or recurrent adrenal cancer. In practical applications, mitotane can be used as a single drug treatment, or it can be combined with surgery, radiotherapy or other drugs to exert a comprehensive effect. Foreign clinical practice shows that mitotane has unique advantages in delaying disease progression and improving patients' quality of life, making it a common choice for long-term maintenance treatment.

In China, the original drug of mitotane is already on the market. However, since adrenal cancer is a rare disease and the number of patients is small, the popularity of the drug and medical insurance coverage are still limited. Currently, mitotane has not been included in the national medical insurance catalog, which means that patients need to purchase the drug at their own expense, which imposes a relatively heavy financial burden. According to market information, the price of each box of mitotane 500mg*100 tablets may be more than 9,000 yuan. Although more expensive, mitotane is often an irreplaceable option for patients requiring long-term treatment.

It is worth mentioning that the treatment of mitotane requires individualized management, and the medication regimen and dosage adjustment of different patients must be dynamically monitored based on blood drug concentration and tolerance. Therefore, even if the price is high, it is still recommended that patients receive treatment in formal medical institutions and develop personalized medication plans through professional doctors. In general, the application value of mitotane in China has been recognized. Although the price is higher, it is still one of the most important treatment options for patients with adrenal cancer.

Reference materials:https://go.drugbank.com/drugs/DB00648